InsidersTradesSigma
Total declarations
Companies
▲ Purchases (439 ops.)
▼ Sales (1 ops.)
Insider track record
OtherDisclosed buys
439
Disclosed sells
1
T+90 hit rate
88%
T+90 mean return
+14.5%
Across 323 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by FROST PHILLIP MD ET AL. Insider active across 7 companies, notably Opko Health, INC.. Cumulatively, 452 disclosures have been recorded. Breakdown: 439 buys · 1 sell. Total volume traded: €20.6m. Activity tracked since 4 May 2021. The latest transaction was filed on 19 May 2025 (J). Regulator: SEC (Form 4). The full history is openly available.
Declarations452 total
909,297 shares@ US$0.00050.9% of flowCommon StockSEC:0001104659-25-051611:0
125,000 shares@ US$1.35770.8% of flowCommon StockSEC:0000950170-25-052925:0
Ideal exit: 5 Jan 2026 (T+270)
125,000 shares@ US$1.47720.9% of flowCommon StockSEC:0000950170-25-052214:0
Ideal exit: 3 Jan 2026 (T+270)
100,000 shares@ US$1.64850.9% of flowCommon StockSEC:0000950170-25-048737:0
Ideal exit: 27 Dec 2025 (T+270)
150,000 shares@ US$1.69591.3% of flowCommon StockSEC:0000950170-25-046952:0
Ideal exit: 23 Dec 2025 (T+270)
459,981 shares@ US$0.00050.5% of flowCommon StockSEC:0001437749-25-009541:0
459,981 shares@ US$0.00050.5% of flowCommon StockSEC:0001437749-25-008804:0
200,000 shares@ US$1.73911.8% of flowCommon StockSEC:0000950170-25-040497:0
Ideal exit: 12 Dec 2025 (T+270)
67,434 shares@ US$1.710.6% of flowCommon StockSEC:0000950170-25-030278:0
Ideal exit: 25 Nov 2025 (T+270)
47,537 shares@ US$1.47380.4% of flowCommon StockSEC:0000950170-25-009978:0
Ideal exit: 25 Oct 2025 (T+270)
150,000 shares@ US$1.46951.2% of flowCommon StockSEC:0000950170-25-006790:0
Ideal exit: 14 Oct 2025 (T+270)
500,000 shares@ US$1.48174.0% of flowCommon StockSEC:0000950170-25-005908:0
Ideal exit: 12 Oct 2025 (T+270)
125,000 shares@ US$1.5951.1% of flowCommon StockSEC:0000950170-24-136264:0
Ideal exit: 9 Sept 2025 (T+270)
647,892 shares@ US$0.00050.7% of flowCommon StockSEC:0001437749-24-037223:0
500,000 shares@ US$1.56214.2% of flowCommon StockSEC:0000950170-24-135471:0
Ideal exit: 7 Sept 2025 (T+270)
199,072 shares@ US$1.5341.6% of flowCommon StockSEC:0000950170-24-131871:0
Ideal exit: 26 Aug 2025 (T+270)
100,000 shares@ US$1.590.9% of flowCommon StockSEC:0000950170-24-130292:0
Ideal exit: 19 Aug 2025 (T+270)
280,183 shares@ US$1.50452.2% of flowCommon StockSEC:0000950170-24-129440:0
Ideal exit: 5 Aug 2025 (T+270)
100,000 shares@ US$1.61980.9% of flowCommon StockSEC:0000950170-24-127266:0
Ideal exit: 11 Aug 2025 (T+270)
280,183 shares@ US$1.50452.2% of flowCommon StockSEC:0000950170-24-124261:0
Ideal exit: 5 Aug 2025 (T+270)
27,100 sharesCommon StockSEC:0001493152-24-040901:0
21,930 shares0Common StockSEC:0001104659-24-107406:0
500,000 shares0Common StockSEC:0000950170-24-087042:0
591,017 shares@ US$0.00050.6% of flowCommon StockSEC:0001437749-24-022293:0
99,230 shares@ US$1.26940.7% of flowCommon StockSEC:0000950170-24-064248:0
Ideal exit: 17 Feb 2025 (T+270)
25 of 452 declarations
About FROST PHILLIP MD ET AL
Frost Phillip MD et al is a significant shareholder of OPKO Health, Inc.
